Client Management | Digital KYC | Transactions | Investor App | AUM & Brokerage Reports | Lead Management | Automated Follow-Ups | MF Research | Multi-Asset Tracking
Login
Get Started
Home Mf Research Aditya Birla Sun Life Pharma Healthcare Fund Regular Plan Growth
Aditya Birla Sun Life Mutual Fund

Mutual Fund Research

Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth

Aditya Birla Sun Life Mutual Fund Equity Equity Sectoral Thematic

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,027.53 +2.75%
Two Week 2026-10-19 ₹1,000.00 ₹1,052.23 +5.22%
One Month 2026-10-05 ₹1,000.00 ₹1,008.53 +0.85%
Three Months 2026-08-05 ₹3,000.00 ₹2,952.35 -1.59%
Six Months 2026-05-07 ₹6,000.00 ₹6,097.84 +1.63%
One Year 2025-11-03 ₹12,000.00 ₹13,085.22 +9.04%
Three Year 2023-11-06 ₹36,000.00 ₹43,284.52 +20.23%
Five Year 2021-11-08 ₹60,000.00 ₹91,112.44 +51.85%
Since Inception 2019-07-10 ₹90,000.00 ₹168,184.66 +86.87%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 74.91%
Healthcare Services 21.61%
Other 2.06%
Insurance 0.73%
Chemicals & Petrochemicals 0.69%

Top Holdings

Company-wise portfolio exposure

Torrent Pharmaceuticals Ltd. 9.28%
Sun Pharmaceutical Industries Ltd. 8.61%
Apollo Hospitals Enterprise Ltd. 6.44%
Cipla Ltd. 6.38%
Aurobindo Pharma Ltd. 4.52%
Sai Life Sciences Ltd. 4.49%
Ajanta Pharma Ltd. 4.35%
Mankind Pharma Ltd. 3.62%
Dr. Lal Path labs Ltd. 3.51%
Abbott India Ltd. 3.26%
Emcure Pharmaceuticals Ltd. 3.21%
Lupin Ltd. 2.94%
IPCA Laboratories Ltd. 2.71%
Gland Pharma Ltd. 2.70%
Fortis Healthcare Ltd. 2.42%
Corona Remedies Ltd. 2.27%
Divi's Laboratories Ltd. 2.24%
Procter & Gamble Health Ltd. 1.82%
Thyrocare Technologies Ltd. 1.76%
Alkem Laboratories Ltd. 1.68%
Jupiter Life Line Hospitals Ltd. 1.55%
Metropolis Healthcare Ltd. 1.48%
Biocon Ltd. 1.45%
Shilpa Medicare Ltd. 1.43%
Piramal Pharma Ltd. 1.22%
Dr. Reddy's Laboratories Ltd. 1.13%
Anthem Biosciences Ltd. 1.13%
Sanofi Consumer Healthcare India Ltd. 1.11%
Suraksha Diagnostic Ltd. 1.10%
Manipal Health Enterprises Ltd 1.07%
Vijaya Diagnostic Centre Ltd. 1.04%
Pfizer Ltd. 1.01%
Natco Pharma Ltd. 0.92%
Glaxosmithkline Pharmaceuticals Ltd. 0.83%
Medi Assist Healthcare Services Ltd. 0.73%
Vinati Organics Ltd. 0.69%
Syngene International Ltd. 0.64%
Max Healthcare Institute Ltd. 0.60%
Jubilant Pharmova Ltd. 0.60%
TREPS 2.92%
Net Receivable / Payable -0.85%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
15.55%
Return volatility
β
Beta
0.91
Benchmark sensitivity
S
Sharpe Ratio
0.87
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Peer Comparison

Compare similar mutual funds by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Nippon India Taiwan Equity Fund - Regular Plan - Growth 59.11% 48.18% 22.89%
HDFC Pharma And Healthcare Fund - Regular Plan - Growth 22.21% 29.08% 28.07%
Kotak Healthcare Fund - Regular Plan - Growth 21.83% 0.00% 19.25%
ICICI Prudential US Bluechip Equity Fund - Regular Plan - Growth 20.17% 18.45% 15.90%
Nippon India - Japan Equity Fund - Regular Plan - Growth 20.05% 20.38% 8.48%
SBI Automotive Opportunities Fund - Regular Plan - Growth 18.72% 0.00% 10.86%
Mirae Asset Healthcare Fund - Regular Plan - Growth 17.38% 22.11% 20.05%
Whiteoak Capital - Pharma And Healthcare Fund - Regular Plan - Growth 17.07% 0.00% 20.11%
Bajaj Finserv Healthcare Fund - Regular Plan - Growth 16.66% 0.00% 8.50%
SBI Healthcare Opportunities Fund - Regular Plan - Growth 16.50% 23.22% 15.44%

Returns are historical and do not guarantee future performance.

View All Equity Sectoral Thematic Funds

Fund Family

Compare schemes from Aditya Birla Sun Life Mutual Fund by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Aditya Birla Sun Life Global Excellence Equity Fund Of Fund - Regular Plan - Growth 19.37% 20.89% 8.17%
Aditya Birla Sun Life Silver ETF - Regular Plan 17.75% 34.32% 23.89%
Aditya Birla Sun Life US Equity Passive FOF - Regular Plan - Growth 17.49% 28.56% 16.89%
Aditya Birla Sun Life Global Emerging Opportunities Fund - Regular Plan - Growth 17.15% 18.78% 14.02%
Aditya Birla Sun Life Silver ETF Fund Of Fund - Regular Plan - Growth 15.78% 32.48% 22.80%
Aditya Birla Sun Life Gold ETF - Regular Plan 13.38% 29.89% 22.50%
Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth 13.11% 19.23% 18.87%
Aditya Birla Sun Life Gold Fund - Regular Plan - Growth 12.45% 29.32% 9.82%
Aditya Birla Sun Life Nifty Healthcare ETF - Regular Plan 12.08% 21.22% 14.17%
Aditya Birla Sun Life Manufacturing Equity Fund - Regular Plan - Growth 11.71% 19.05% 11.96%

Returns are historical and do not guarantee future performance.

View All Aditya Birla Sun Life Mutual Fund Funds

Scheme Objective

The investment mandate and purpose of this scheme

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.29%
Expense Ratio (Direct)
1.07%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare TRI

Exit Load

Charges that may apply when you redeem units

For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil
Top AMC/Fund Houses
360 ONE Mutual Fund AMC logo
360 ONE Mutual Fund
AUM
₹13,053 Cr
Age
15+ Years
Aditya Birla Sun Life Mutual Fund AMC logo
Aditya Birla Sun Life Mutual Fund
AUM
₹4.36 Lakh Cr
Age
31+ Years
Helios Mutual Fund AMC logo
Helios Mutual Fund
AUM
₹9,401 Cr
Age
1–2 Years
Bandhan Mutual Fund AMC logo
Bandhan Mutual Fund
AUM
₹1.78+ Lakh Cr
Age
4 Years
view all

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?